BTT-3033
BTT-3033 is an orally active and potent α2β1 (EC50: 130 nM) inhibitor with an affinity for the α2I domain, inhibiting platelet binding to collagen I and cell proliferation. BTT-3033 induces apoptosis and can be used to study prostate cancer, inflammation, and cardiovascular disease.
Product Specifications
CAS Number
1259028-99-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
465.5
Molecular Formula
C23H20FN5O3S
Notes
Research use only, not for human use.
Receptor
Apoptosis | Integrin
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ZFP385C-10348M 50 µg
Recombinant Mouse ZFP385C Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
SLY4360Hu-01 96 Tests
Human Anti-Phosphatidic acid antibody (APA) ELISA Kit
Sign In for Pricing
View Details 
SLY4360Hu-02 48 Tests
Human Anti-Phosphatidic acid antibody (APA) ELISA Kit
Sign In for Pricing
View Details MBS1106405-01 0.02 mg (E-Coli)
Recombinant Pyrobaculum calidifontis Geranylgeranylglyceryl phosphate synthase (Pcal_0985)
Sign In for Pricing
View Details